Disease severity and outcome in thymoma myasthenia gravis: a long-term observation study.
Romi, F
Disease severity and outcome in thymoma myasthenia gravis: a long-term observation study. [electronic resource] - European journal of neurology Nov 2003 - 701-6 p. digital
Publication Type: Journal Article
1351-5101
10.1046/j.1468-1331.2003.00678.x doi
Adrenal Cortex Hormones--therapeutic use
Adult
Age of Onset
Autoantibodies--immunology
Azathioprine--therapeutic use
Combined Modality Therapy
Connectin
Female
Humans
Immunosuppressive Agents--therapeutic use
Male
Middle Aged
Muscle Proteins--immunology
Myasthenia Gravis--complications
Protein Kinases--immunology
Receptors, Cholinergic--immunology
Ryanodine Receptor Calcium Release Channel--immunology
Thymectomy
Thymoma--etiology
Thymus Gland--pathology
Thymus Neoplasms--etiology
Treatment Outcome
Disease severity and outcome in thymoma myasthenia gravis: a long-term observation study. [electronic resource] - European journal of neurology Nov 2003 - 701-6 p. digital
Publication Type: Journal Article
1351-5101
10.1046/j.1468-1331.2003.00678.x doi
Adrenal Cortex Hormones--therapeutic use
Adult
Age of Onset
Autoantibodies--immunology
Azathioprine--therapeutic use
Combined Modality Therapy
Connectin
Female
Humans
Immunosuppressive Agents--therapeutic use
Male
Middle Aged
Muscle Proteins--immunology
Myasthenia Gravis--complications
Protein Kinases--immunology
Receptors, Cholinergic--immunology
Ryanodine Receptor Calcium Release Channel--immunology
Thymectomy
Thymoma--etiology
Thymus Gland--pathology
Thymus Neoplasms--etiology
Treatment Outcome